Skip to content

Clinical trials

Terminated Phase 3 Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 3 Status: Terminated Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20072
20091
20132
20142
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ophthotech Corporation3
Alcon Research2
Novartis Pharmaceuticals2
Asociación para Evitar la Ceguera en México1
Genaera Corporation1
OPKO Health, Inc.1
Opthea Limited1
UCB Pharma1
University of Athens1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration13
Choroidal Neovascularization4
Diabetes Mellitus2
Macular Edema2
Diabetic Retinopathy1
Eye Diseases1
Geographic Atrophy1
Neovascularization, Pathologic1
Neurofibromatosis 21
Retinal Degeneration1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.